August 18-21, 2016

Swissotel Chicago
Chicago, IL

Tuesday, July 19, 2011

ZymoGenetics- Exhibitor


Founded in 1981, ZymoGenetics is a biopharmaceutical company focused on the development and commercialization of therapeutic proteins.

As a leader in recombinant technology with three decades of drug discovery and development experience, ZymoGenetics discovered and/or developed eight recombinant proteins that are currently available on the market. In addition, multiple product candidates have been out-licensed through its research efforts.

Seven are being marketed by other companies, and the eighth – RECOTHROM® Thrombin, topical (Recombinant) – is the first product that ZymoGenetics has commercialized and marketed in the US.

In October 2010, ZymoGenetics was acquired by Bristol-Myers Squibb.


  1. Hello Tracy,

    Could you please remove my link in the above comment along with keyword: Recovery from Hip Replacement?

    We do not want link back to our website from this keyword.

    Thank you,
    ZehrCenter Team